NATIONAL ATHLETICS NEWS - Semenya made no comment as she arrived at the court in Lausanne for the start of a week-long hearing that could define the rest of the 28-year-old’s career.
The South African government has said the rules set out by track and field’s governing body, the International Association of Athletics Federations (IAAF), specifically target Semenya and has called them a “gross violation” of her human rights.
The controversial measures would force so-called “hyperandrogenic” athletes or those with “differences of sexual development” (DSD) to take drugs to lower their testosterone levels below a prescribed amount if they wish to continue competing.
The rules were to have been introduced last November but have been put on hold pending this week’s hearings. A judgement is expected at the end of March.
IAAF President Sebastian Coe, arriving at the court, said: “Today is a very, very important day.
“The regulations that we are introducing are there to protect the sanctity of fair and open competition.”
The chief advocate for Athletics South Africa, Norman Arendse, said Semenya would give evidence.
“The whole week is going to be important. Obviously the evidence will be evaluated and assessed at the end of the process this week. so today this is the start,” he told reporters.
The issue is highly emotive.
When British newspaper The Times reported last week that the IAAF would argue that Semenya should be classified as a biological male — a claim later denied by the IAAF — she hit back, saying she was “unquestionably a woman”.
In response to the report, the IAAF — stressing it was referring in general terms, not to Semenya in particular — denied it intended to classify any DSD athlete as male.
But in a statement, it added: “If a DSD athlete has testes and male levels of testosterone, they get the same increases in bone and muscle size and strength and increases in haemoglobin that a male gets when they go through puberty, which is what gives men such a performance advantage over women.
“Therefore, to preserve fair competition in the female category, it is necessary to require DSD athletes to reduce their testosterone down to female levels before they compete at international level.”
Semenya is not the only athlete potentially affected — the silver and bronze medallists in the Rio Olympics 800m, Francine Niyonsaba of Burundi and Kenya’s Margaret Wambui, have also faced questions about their testosterone levels.
But it is Semenya, who also won Olympic gold in 2012 and has three world titles to her name, who has led opposition to the proposed rules.
Matthieu Reeb, CAS Secretary General, said the case was highly unusual.
“It is unusual and unprecedented because we never had a such a case at CAS,” he said. “What is going to happen I am not able to say, but it is going to be important for sure.”
South Africa’s Sports Minister Tokozile Xasa argues that the rules are “discriminatory”.
“What’s at stake here is far more than the right to participate in a sport. Women’s bodies, their wellbeing, their ability to earn a livelihood, their very identity, their privacy and sense of safety and belonging in the world, are being questioned,” Xasa said on Friday.
On Sunday, tennis great Martina Navratilova threw her weight behind Semenya.
The 18-time Grand Slam singles winner said it was significant that the rules would only apply to female athletes competing in distances from 400m to a mile.
“Leaving out sprints and longer distances seems to me to be a clear case of discrimination by targeting Semenya,” Navratilova wrote in Britain’s Sunday Times newspaper.
“And can it be right to order athletes to take medication? What if the long-term effects proved harmful?… I hope she wins.”